Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2834)
All Articles published online
|
May 28, 2005 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nemoto T, Kubota S, Ishida H, Murata N, Hashimoto D. Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors. World J Gastroenterol 2005; 11(20): 3065-3069 [PMID: 15918191 DOI: 10.3748/wjg.v11.i20.3065] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3065.htm |
| Number | Citing Articles |
| 1 |
Jen Jen Yeh, Elizabeth D. Routh, Tara Rubinas, Janie Peacock, Timothy D. Martin, Xiang Jun Shen, Robert S. Sandler, Hong Jin Kim, Temitope O. Keku, Channing J. Der.
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Molecular Cancer Therapeutics 2009; 8(4): 834 doi: 10.1158/1535-7163.MCT-08-0972
|
| 2 |
Kuen Kuen Lam, Choong Leong Tang, Emile Tan, Siew Heng Wong, Peh Yean Cheah. KRAS mutation‐independent downregulation of MAPK/PI3K signaling in colorectal cancer. Molecular Oncology 2022; 16(5): 1171 doi: 10.1002/1878-0261.13163
|
| 3 |
Hae-Young Yong, Min-Soo Koh, Aree Moon. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opinion on Investigational Drugs 2009; 18(12): 1893 doi: 10.1517/13543780903321490
|
| 4 |
Jia-Fei Poon, John Patrick Alao, Per Sunnerhagen, Peter Dinér. Azastilbenes: a cut-off to p38 MAPK inhibitors. Organic & Biomolecular Chemistry 2013; 11(27): 4526 doi: 10.1039/c3ob27449g
|
| 5 |
Li-Xin Kong, Zheng Wang, Yu-Ke Shou, Xue-Dong Zhou, Ya-Wen Zong, Ting Tong, Min Liao, Qi Han, Yan Li, Lei Cheng, Biao Ren. The FnBPA from methicillin-resistant Staphylococcus aureus promoted development of oral squamous cell carcinoma. Journal of Oral Microbiology 2022; 14(1) doi: 10.1080/20002297.2022.2098644
|
| 6 |
Anja H. Wiese, Johannes Auer, Silke Lassmann, Jörg Nährig, Robert Rosenberg, Heinz Höfler, Rüdiger Rüger, Martin Werner. Identification of gene signatures for invasive colorectal tumor cells. Cancer Detection and Prevention 2007; 31(4): 282 doi: 10.1016/j.cdp.2007.07.003
|
| 7 |
Ioannis A. Voutsadakis. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox‐2. Journal of Cellular and Molecular Medicine 2007; 11(2): 252 doi: 10.1111/j.1582-4934.2007.00032.x
|
| 8 |
YUTAKA HOSHINO, SHINYA TERASHIMA, YASUSHI TERANISHI, MASANORI TERASHIMA, MICHIHIKO KOGURE, TAKUROH SAITOH, FUMIHIKO OSUKA, SEIGO KASHIMURA, ZENICHIROH SAZE, MITSUKAZU GOTOH. ORNITHINE DECARBOXYLASE ACTIVITY AS A PROGNOSTIC MARKER FOR COLORECTAL CANCER. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 2007; 53(1): 1 doi: 10.5387/fms.53.1
|
| 9 |
Einat Gochman, Jamal Mahajna, Pessia Shenzer, Aviva Dahan, Alexandra Blatt, Rami Elyakim, Abraham Z. Reznick. The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochemica 2012; 114(8): 827 doi: 10.1016/j.acthis.2012.02.004
|
| 10 |
Habib Zarredar, Khalil Ansarin, Behzad Baradaran, Shiva Ahdi Khosroshahi, Safar Farajnia. Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology. Cancer Investigation 2018; 36(1): 37 doi: 10.1080/07357907.2017.1416393
|
| 11 |
Ling Yang, Xiaoting Sun, Ying Ye, Yongtian Lu, Ji Zuo, Wen Liu, Adrian Elcock, Shun Zhu. p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01294
|